Trial Profile

A Randomized, Double-blind, Placebo-controlled, Dose Escalation Phase I Study Assessing the Safety and Immune Response of PPV-06 Vaccine in Patient With Inflammatory Knee Osteoarthritis (KOA)

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 28 Feb 2025

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs PPV-06 (Primary) ; Montanide ISA-51
Indications Osteoarthritis
Focus Adverse reactions; First in man
Sponsors Peptinov

Most Recent Events

15 Jun 2024 Results assessing safety, tolerability and immune response of PPV-06 vaccine in participants with inflammatory KOA presented at the 25th Annual Congress of the European League Against Rheumatism
30 May 2024 Status changed from recruiting to completed.
25 Apr 2022 Planned End Date changed from 1 Apr 2022 to 28 Feb 2023.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com